{"date":"2026-06-15","count":23,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6483-2026-06-15-2340-2cu07m","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"23:40:51","subject":"公告本公司收到「用於上呼吸道給藥之組成物及其給藥方法」之歐洲專利核准通知書","clause":"第44款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-06-15 23:40，「公告本公司收到「用於上呼吸道給藥之組成物及其給藥方法」之歐洲專利核准通知書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-06-15-1847-14ztyfn","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-06-15","time":"18:47:18","subject":"公告本公司董事長決定現金股利配息及資本公積發放現金基準日","clause":"第14款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-06-15 18:47，「公告本公司董事長決定現金股利配息及資本公積發放現金基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-06-15-1743-t1kjpr","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"17:43:05","subject":"公告本公司新任審計委員會委員名單","clause":"第6款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-06-15 17:43，「公告本公司新任審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-06-15-1742-czorub","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"17:42:43","subject":"公告本公司115年股東常會決議解除新任董事競業禁止限制","clause":"第22款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-06-15 17:42，「公告本公司115年股東常會決議解除新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-06-15-1742-rd945c","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"17:42:23","subject":"公告本公司115年股東常會增補選獨立董事二席當選名單","clause":"第6款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-06-15 17:42，「公告本公司115年股東常會增補選獨立董事二席當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-06-15-1742-15e1v8f","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"17:42:02","subject":"本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-06-15 17:42，「本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-06-15-1740-1jb8ii5","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-06-15","time":"17:40:21","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-06-15 17:40，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-06-15-1702-1u737ew","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-06-15","time":"17:02:43","subject":"公告本公司股票初次上櫃前現金增資競價拍賣，因合格標不足故不開標","clause":"第44款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-06-15 17:02，「公告本公司股票初次上櫃前現金增資競價拍賣，因合格標不足故不開標」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-06-15-1656-15820f8","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-06-15","time":"16:56:07","subject":"本公司董事會通過對關係人捐贈事宜","clause":"第43款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-06-15 16:56，「本公司董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-06-15-1655-sp6xik","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-06-15","time":"16:55:47","subject":"公告本公司董事會決議除息基準日等相關事宜。","clause":"第14款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-06-15 16:55，「公告本公司董事會決議除息基準日等相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-06-15-1640-1eishuo","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"16:40:45","subject":"公告本公司115年股東常會補選第四屆二席董事及一席獨立董事當選名單暨董事變動達三分之一 (更正新任者選任時持股數)","clause":"第6款","fact_date":"2026-06-12","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-06-15 16:40，「公告本公司115年股東常會補選第四屆二席董事及一席獨立董事當選名單暨董事變動達三分之一 (更正新任者選任時持股數)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-06-15-1617-1flnovf","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"16:17:20","subject":"公告本公司115年度股東常會決議解除新任董事競業禁止限制案","clause":"第22款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-06-15 16:17，「公告本公司115年度股東常會決議解除新任董事競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-06-15-1616-3il1nf","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"16:16:38","subject":"公告本公司115年度股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-06-15 16:16，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-06-15-1557-18aqq8t","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"15:57:15","subject":"公告本公司董事會決議以私募方式辦理國內第一次轉換公司債","clause":"第9款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-06-15 15:57，「公告本公司董事會決議以私募方式辦理國內第一次轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-06-15-1554-wdyk0k","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"15:54:13","subject":"本公司董事會決議召開115年第一次股東臨時會公告","clause":"第32款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-06-15 15:54，「本公司董事會決議召開115年第一次股東臨時會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-06-15-1541-12yzsf1","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"15:41:32","subject":"公告本公司受邀參加群益金⿍證券與IR Trust舉辦之「再生醫療與消費醫療產業」論壇","clause":"第30款","fact_date":"2026-07-02","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-06-15 15:41，「公告本公司受邀參加群益金⿍證券與IR Trust舉辦之「再生醫療與消費醫療產業」論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-06-15-1538-1biy3xk","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-06-15","time":"15:38:09","subject":"公告本公司115年度現金增資收足股款暨增資基準日","clause":"第44款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-06-15 15:38，「公告本公司115年度現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-06-15-1506-x0wnam","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-15","time":"15:06:53","subject":"代子公司共信醫藥科技股份有限公司公告重新選任法人董事及法人監察人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-06-15 15:06，「代子公司共信醫藥科技股份有限公司公告重新選任法人董事及法人監察人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-06-15-1454-t36opm","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-15","time":"14:54:24","subject":"公告本公司115年5月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-06-15 14:54，「公告本公司115年5月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-06-15-1431-uzhvw4","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-06-15","time":"14:31:05","subject":"本公司與義大醫療財團法人義大醫院簽署加速器型硼中子捕獲治療（AB-BNCT）中心建置合作意向書","clause":"第10款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-06-15 14:31，「本公司與義大醫療財團法人義大醫院簽署加速器型硼中子捕獲治療（AB-BNCT）中心建置合作意向書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-06-15-1418-18bhctm","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-06-15","time":"14:18:46","subject":"公告本公司初次上櫃掛牌首五個營業日穩定價格操作結果","clause":"第53款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-06-15 14:18，「公告本公司初次上櫃掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-06-15-1405-1xzaz9h","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-06-15","time":"14:05:02","subject":"代子公司「中化裕民健康事業股份有限公司」公告董事會解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-06-15 14:05，「代子公司「中化裕民健康事業股份有限公司」公告董事會解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-06-15-1345-1ipy30","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-06-15","time":"13:45:28","subject":"公告本公司董事會決議股利配發基準日","clause":"第14款","fact_date":"2026-06-15","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-06-15 13:45，「公告本公司董事會決議股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}